United States Government Publishing Office publisher pbl distributor dst United States Congress House of Representatives author aut Government Organization text government publication eng BILLS Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.;H. Res. 242 (IH) Bills and Statutes 116_cong_bills legislative 2019-03-18 U.S. Government Publishing Office 2019-03-18 monographic deposited born digital 3 p. Y 1.6: Y 1.4/7: P0b002ee19ffbdf24 https://www.govinfo.gov/app/details/BILLS-116hres242ih H. Res. 242 021-610-00252-9 000501532 000325574 Congressional bills House resolutions f:hr242_ih.txt https://www.govinfo.gov/app/details/BILLS-116hres242ih https://www.govinfo.gov/content/pkg/BILLS-116hres242ih/html/BILLS-116hres242ih.htm https://www.govinfo.gov/content/pkg/BILLS-116hres242ih/pdf/BILLS-116hres242ih.pdf https://www.govinfo.gov/content/pkg/BILLS-116hres242ih/xml/BILLS-116hres242ih.xml fdlp DGPO 2019-03-18 2023-01-02 BILLS-116hres242ih machine generated eng G. K. Butterfield United States House of Representatives sponsor spn United States Congress Member Gus M. Bilirakis United States House of Representatives cosponsor United States Congress Member United States Congress House of Representatives Committee on Energy and Commerce associated name asn hres BILLS-116hres242ih 116 1 HOUSE HOUSE 242 ih ih Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases. Mr. Butterfield (for himself and Mr. Bilirakis) submitted the following resolution; which was referred to the Committee on Energy and Commerce Committee on Energy and Commerce Energy and Commerce Mr. Butterfield G. K. Butterfield Butterfield, G. K. Mr. Bilirakis Gus M. Bilirakis Bilirakis, Gus M. Mr. Gus Bilirakis false false